跳转至内容
Merck
CN

05-3710

2-氯苯酚

SAJ first grade, ≥99.0%

登录 查看组织和合同定价。

选择尺寸

变更视图

关于此项目

线性分子式:
ClC6H4OH
化学文摘社编号:
分子量:
128.56
EC Number:
202-433-2
UNSPSC Code:
12352104
PubChem Substance ID:
Beilstein/REAXYS Number:
1905114
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助


grade

SAJ first grade

assay

≥99.0%

availability

available only in Japan

refractive index

n20/D 1.558 (lit.)

bp

175-176 °C (lit.)

mp

8 °C (lit.)

density

1.241 g/mL at 25 °C (lit.)

SMILES string

Oc1ccccc1Cl

InChI

1S/C6H5ClO/c7-5-3-1-2-4-6(5)8/h1-4,8H

InChI key

ISPYQTSUDJAMAB-UHFFFAOYSA-N



Still not finding the right product?

Explore all of our products under 2-氯苯酚


signalword

Danger

Hazard Classifications

Acute Tox. 4 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Eye Dam. 1 - Skin Corr. 1B

存储类别

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 2

flash_point_f

147.2 °F - closed cup

flash_point_c

64.0 °C - closed cup

ppe

Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter

法规信息

新产品

此项目有



历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库



Chengyang Wu et al.
Water research, 188, 116465-116465 (2020-10-14)
We created a hydrogen-based membrane palladium-film reactor (MPfR) by depositing palladium nanoparticles (PdNPs) on hollow-fiber membranes via autocatalytic hydrogenation to form a Pd-film. The MPfR was used for hydrodechlorination (HDC) of 2,4-dichlorophenol (2,4-DCP). HDC performances and mechanisms were systematically evaluated
Thi Thu Nga Nguyen et al.
The Journal of antimicrobial chemotherapy, 70(3), 731-738 (2014-10-23)
HIV resistance to the integrase inhibitor raltegravir in treated patients is characterized by distinct resistance pathways. We hypothesize that differences in the in vivo dynamics of HIV resistance to raltegravir are due to the genetic context of the integrase present
Julio Alonso-Padilla et al.
PLoS neglected tropical diseases, 8(12), e3259-e3259 (2014-12-05)
The discovery of new therapeutic options against Trypanosoma cruzi, the causative agent of Chagas disease, stands as a fundamental need. Currently, there are only two drugs available to treat this neglected disease, which represents a major public health problem in